Understanding how T-cell memory works to improve immune responses

An experimentally-refined, dynamic gene regulatory network model of T-cell memory

NIH-funded research Cincinnati Childrens Hosp Med Ctr · NIH-11042256

This study is looking into how our immune system's T-cells remember past infections so they can respond quickly if the same germs come back, which could help improve vaccines and treatments for everyone.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionCincinnati Childrens Hosp Med Ctr NIH-funded
Lab location1 site (Cincinnati, United States)
Project IDNIH-11042256 on NIH RePORTER

What this research studies

This research investigates the mechanisms behind T-cell memory, which is crucial for the immune system's ability to respond quickly to previously encountered pathogens. By examining the gene regulatory networks that control T-cell memory, the study aims to uncover how these cells maintain their ability to respond effectively over long periods. The approach involves advanced techniques to analyze the epigenetic changes in T-cells, which may reveal insights into their rapid recall capabilities and potential links to autoimmune diseases. Patients may benefit from a better understanding of how to enhance immune responses through vaccination or other therapies.

Who could benefit from this research

Good fit: Ideal candidates for this research include individuals with a history of autoimmune diseases or those interested in understanding their immune response to vaccinations.

Not a fit: Patients who do not have any history of immune-related conditions or those not interested in vaccination strategies may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to improved vaccines and therapies that enhance immune memory, providing better protection against infections and autoimmune diseases.

How similar studies have performed: Previous research has shown promising results in understanding T-cell memory and its implications for vaccine development, indicating that this area of study is both relevant and potentially impactful.

Where this research is happening

Cincinnati, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Allergic Diseaseanti-cancer
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.